Speaker illustration

Doctor Sergiy Pyvovar

L.T.Malaya Institute of Therapy, Kharkiv (Ukraine)

Has been working as a senior researcher at the Department of Noncommunicable Diseases Clinical Pharmacology and Pharmacogenetics since 2004. The main field of scientific activity is the influence of pharmacogenetic factors on the heart failure course and the therapy efficiency. He is studying of the features of the heart failure course in patients with the “low triiodothyronine” syndrome. Clinical interests are cardiac rhythm and conduction disorders, heart failure.

The significance of the level of triiodothyronium in the diagnosis of the syndrome of "low triiodothyronine" in heart failure

Event: ESC Congress 2021 - The Digital Experience

Topic: Pathophysiology

Session: Chronic heart failure e-posters


The association of Beta-adrenoreception system genes polymorphisms and interleukins levels in patients with heart failure

Event: Heart Failure 2021

Topic: Pathophysiology

Session: ePoster session


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb